Cargando…
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
BACKGROUND: Prostate cancer is characterized by heterogeneity in the clinical course that often does not correlate with morphologic features of the tumor. Metastasis reflects the most adverse outcome of prostate cancer, and to date there are no reliable morphologic features or serum biomarkers that...
Autores principales: | Chandran, Uma R, Ma, Changqing, Dhir, Rajiv, Bisceglia, Michelle, Lyons-Weiler, Maureen, Liang, Wenjing, Michalopoulos, George, Becich, Michael, Monzon, Federico A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865555/ https://www.ncbi.nlm.nih.gov/pubmed/17430594 http://dx.doi.org/10.1186/1471-2407-7-64 |
Ejemplares similares
-
Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
por: Chandran, Uma R, et al.
Publicado: (2005) -
Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011) -
The yin and yang of 15-lipoxygenase-1 and delta-desaturases: Dietary omega-6 linoleic acid metabolic pathway in prostate
por: Kelavkar, Uddhav, et al.
Publicado: (2006) -
Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011) -
Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011)